Filing Flows › Cryo Cell International (CCEL) › Q3 FY25
Cryo Cell International (CCEL) Q3 FY25 earnings results (third quarter fiscal 2025)
10-Q filed Oct 15, 2025
Cryo Cell International (CCEL) reported revenue of $7.8M for the third quarter fiscal 2025 (Q3 FY25), -3% from a year earlier and -1% from the quarter before. Operating margin was 24.3%, net earnings $749K (9.6% of revenue).
Cryo Cell International, Q3 FY25: revenue $7.8M (-3% year over year), operating margin 24.3%, net earnings $749K, operating cash flow $2.5M. The chart follows the revenue to costs, profit and cash.
| Q3 FY25 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.8M | -1% | -3% |
| Operating profit | $1.9M | +27% | +37% |
| Net earnings | $749K | +111% | -29% |
| Operating cash flow | $2.5M | +259% | +4% |
| Free cash flow | $2.5M | +288% | +11% |
What changed
Revenue was $7.8M in Q3 FY25, down 3% year over year and down 1% from the previous quarter. Processing and Storage Fees was the largest line at 100% of revenue. Processing and Storage Fees lost $125K year over year (down 2%), 52% of the total change.
Operating profit was $1.9M, a 24.3% margin (up 7.1 points year over year). Total costs fell 11% while revenue fell 3%. Net earnings were $749K, down 29% year over year. The effective tax rate was 36.8%.
Operating cash flow was $2.5M (up 4% year over year), 338% of net earnings. Non-cash charges added back $244K of depreciation and amortization and $37K of share-based compensation. Working capital and other items added $1.5M. Capital expenditures of $39K left free cash flow of $2.5M.
Questions
What was Cryo Cell International's revenue in the third quarter fiscal 2025?
Cryo Cell International (CCEL) reported revenue of $7.8M for the third quarter fiscal 2025 (Q3 FY25), -3% from a year earlier and -1% from the quarter before.
Was Cryo Cell International profitable in the third quarter fiscal 2025?
Operating profit was $1.9M (24.3% of revenue) and net earnings $749K.